SINOGEN BIOPHARMA
Sinogen Biopharma is founded with a vision to bridge China's biotech innovation to the US pharma market. The company licenses and develops innovative drugs from China.
SINOGEN BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.sinogenchina.com
Status:
Active
Total Funding:
13 M USD
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Investors List
Winzac Capital
Winzac Capital investment in Series A - Sinogen Biopharma
Westlake Village BioPartners
Westlake Village BioPartners investment in Series A - Sinogen Biopharma
CHERAMI
CHERAMI investment in Series A - Sinogen Biopharma
Qiming Venture Partners
Qiming Venture Partners investment in Venture Round - Sinogen Biopharma
More informations about "Sinogen Biopharma"
Guangzhou Sinogen Pharmaceutical - VentureRadar
Website: http://www.sinogenchina.com/ Develops and manufactures anticancer drugs with high potency and cytotoxic characteristics, focusing on pancreatic, liver, lung, and three-negative …See details»
Sinogen Biopharma - Crunchbase Company Profile
Sinogen Biopharma is founded with a vision to bridge China's biotech innovation to the US pharma market. The company licenses and develops innovative drugs from China. A genetically engineered oncolytic bacterium that targets and …See details»
Guangzhou Sinogen Pharmaceutical Co., Ltd.
Guangzhou Sinogen Pharmaceutical Co., Ltd. is a biotechnology company committed to the development and production of innovative biological oncology drugs to meet the global …See details»
Sinogen China Ltd - Company Profile and News - Bloomberg …
Company profile page for Sinogen China Ltd including stock price, company news, executives, board members, and contact informationSee details»
Sinogen Pharmaceutical - PitchBook
Developer and manufacturer of bacterial carrier-based biological anti-tumor drugs for the treatment of malignant tumors. The company focuses on the field of metastatic tumors and …See details»
Sinogen Biopharma Inc - VentureRadar
Develops innovative biological anti-tumor drugs, leveraging a unique oncolytic bacteria technology platform, with a focus on international clinical trials.See details»
SinoGen International - PitchBook
Provider of drug distribution services based in China. The company offers a platform for biopharmaceuticals and biotechnology drugs. Want detailed data on 3M+ companies? Want to …See details»
SinoGeneclon
Sinogeneclon Co., Ltd established in Hangzhou , China in 2007, Sinogeneclon is a professional company which focuses on life sciences products and biotechnology. Our main business includes recombinant proteins and …See details»
Sinogen Biopharma - Funding, Financials, Valuation & Investors
Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.See details»
Huajin - Products, Competitors, Financials, Employees, …
Huajin develops and produces biological antitumor drugs to meet the needs of the global malignant tumor treatment market. Its products include SGN1 (SalMet-Vec), a genetically …See details»
Sinogen Biopharma - Updates, News, Events, Signals & Triggers
Dec 31, 2023 · Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.See details»
Guangzhou Huajin Pharmaceutical Technology Co., Ltd
Objectives: To characterize safety, tolerability, MTD and OBD of intratumoral injection of SGN1 in patients with advanced solid tumors, and to preliminarily investigate the efficacy and safety of …See details»
10 Leading Antibody Contract Manufacturing Organizations …
Sep 20, 2024 · Here we list the top antibody contract manufacturers in China. They provide solutions for antibody development, from discovery to commercial-scale production. This list is …See details»
Vision 2028: How China could impact the global biopharma industry
China-originated innovation that is already commercialized is BeiGene’s zanubrutinib. Sold under the brand name Brunkinsa, zanubrutinib received breakthrough therapy designation, orphan …See details»
Sinogene Biotechnology - Wikipedia
Sinogene Biotechnology is a Chinese biotechnology company, focusing on animal cloning technology for consumers. [1][2] Their pet cloning services include: dog, [3][4] cat, [5][6] cow, …See details»
Sinopharm: Chinese Covid vaccine gets WHO emergency approval …
May 7, 2021 · The World Health Organization (WHO) has granted emergency approval for a Covid vaccine made by Chinese state-owned company Sinopharm. It is the first vaccine …See details»
SINOGENE - Crunchbase Company Profile & Funding
SINOGENE creates an animal gene editing and somatic cell cloning technology platform. Sinogene uses a solution called somatic cell nuclear transfer for pet cloning. Sinogene …See details»
赛诺根（中国）有限公司 - 企查查
Dec 11, 2020 · 企查查为您提供赛诺根（中国）有限公司的最新工商信息、公司简介、公司地址、电话号码、招聘信息、信用信息、财务信息、法律诉讼等多维度详细信息查询，让您对赛诺 …See details»
Covid: What do we know about China's coronavirus vaccines? - BBC
Jul 13, 2021 · Both Sinopharm and Sinovac, which have been approved by the World Health Organization (WHO) for emergency use, are already being used in China and dozens of …See details»
How Many NGOs Are There Really in China?
Aug 2, 2019 · When foreign observers offer estimates of the number of NGOs in China, they tend to base themselves upon the number of “social organizations” (社会组织) that have officially …See details»